Zurich Cantonal Bank’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,792
| Closed | -$407K | – | 2882 |
|
|
2023
Q1 | $407K | Buy |
3,792
+1,139
| +43% | +$122K | ﹤0.01% | 1415 |
|
|
2022
Q4 | $292K | Sell |
2,653
-244
| -8% | -$26.8K | ﹤0.01% | 1585 |
|
|
2022
Q3 | $171K | Buy |
2,897
+662
| +30% | +$39.1K | ﹤0.01% | 1843 |
|
|
2022
Q2 | $63K | Sell |
2,235
-54
| -2% | -$1.52K | ﹤0.01% | 2490 |
|
|
2022
Q1 | $86K | Buy |
+2,289
| New | +$86K | ﹤0.01% | 2346 |
|